• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vistagen Therapeutics, Inc. - Common Stock (NQ:VTGN)

0.2580 +0.0088 (+3.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vistagen Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Unusual volume stocks in Thursday's session ↗
July 02, 2026
Via Chartmill
Here are the top movers in Tuesday's session. ↗
June 30, 2026
Via Chartmill
Top movers analysis in the middle of the day on 2026-06-30: top gainers and losers in today's session. ↗
June 30, 2026
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
June 30, 2026
Via Chartmill
Vistagen Therapeutics (NASDAQ:VTGN) Faces Muted Market Sentiment as Crucial PALISADE-4 Data Looms ↗
June 15, 2026
Via Chartmill
Vistagen Therapeutics Inc (NASDAQ:VTGN) Reports Mixed Q3 Results Amid Key Clinical Trial Updates ↗
February 12, 2026
Via Chartmill
Why Did Vistagen Stock Tank 82% Today? ↗
December 17, 2025
Via Stocktwits
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
 
Via Benzinga
News headline image
Insights into VistaGen Therapeutics's Upcoming Earnings ↗
June 16, 2025
 
Via Benzinga
What's going on in today's pre-market session ↗
February 13, 2026
Via Chartmill
News headline image
VistaGen (VTGN) Q3 2026 Earnings Call Transcript ↗
February 12, 2026
VistaGen (VTGN) Q3 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
Which stocks are moving after the closing bell on Thursday? ↗
February 12, 2026
Via Chartmill
News headline image
These stocks have an unusual volume in today's session ↗
December 22, 2025
Let's explore the current happenings on the US markets on Monday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
Via Chartmill
News headline image
Earnings Scheduled For February 13, 2025 ↗
February 13, 2025
 
Via Benzinga
News headline image
On Friday, there are stocks with unusual volume. Let's take a look. ↗
December 19, 2025
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
News headline image
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
December 18, 2025
Let's have a look at the stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
November 17, 2025
 
Via Benzinga
News headline image
Vistagen (VTGN) Q2 2026 Earnings Call Transcript ↗
November 14, 2025
Vistagen (VTGN) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Examining the Future: VistaGen Therapeutics's Earnings Outlook ↗
November 12, 2025
 
Via Benzinga
News headline image
Vistagen (VTGN) Q1 R&D Expense Jumps 54% ↗
August 07, 2025
Via The Motley Fool
News headline image
Insights Ahead: VistaGen Therapeutics's Quarterly Earnings ↗
August 06, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For June 17, 2025 ↗
June 17, 2025
 
Via Benzinga
News headline image
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025 ↗
August 13, 2024
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025. 
Via InvestorPlace
News headline image
3 Stocks Under $15 That Could Make You a Millionaire ↗
July 26, 2024
Investors looking for millionaire status in the coming years should consider three stocks under $15 that could be worth buying. 
Via InvestorPlace
News headline image
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024 ↗
June 12, 2024
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024. 
Via InvestorPlace
News headline image
3 Must-Have Penny Stocks to Boost Your 2024 Portfolio ↗
May 14, 2024
Though volatility remains high, these penny stocks promise significant returns, especially in this high-interest rate economic climate. 
Via InvestorPlace
News headline image
Meme Stock Rebound: 3 Reddit Favorites Primed for a Resurgence ↗
May 13, 2024
The internet and forums such as Reddit, are rife with misinformation about stock prospects. However, these three might have potential. 
Via InvestorPlace
News headline image
7 Stocks Under $15 Predicted to Boom in the Next 2 Years ↗
April 19, 2024
Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy. 
Via InvestorPlace
News headline image
Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027 ↗
April 09, 2024
Explore three stocks under $10 in electronic equipment and instruments, technology hardware, storage and peripherals, and biotechnology. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap